Role of renal eicosanoids in the control of intraglomerular and systemic blood pressure during development of hypertension

Contributions to Nephrology

Volumn 143, Issue , 2004, Pages 65-76

  Arima, Shuji ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; PROSTAGLANDIN;

ANIMAL; BLOOD PRESSURE; GLOMERULUS; HUMAN; HYPERTENSION; KIDNEY; PHYSIOLOGY; REVIEW; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; EICOSANOIDS; HUMANS; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; PROSTAGLANDINS; SODIUM CHLORIDE, DIETARY;

EID: 3242705163     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000078712     Document Type: Article

References (55)

1. Abe K, Ito S: The kidney and hypertension. Hypertens Res 1997;20:75-84.
2. Ito S: Kidney and hypertension: Role of juxtaglomerular apparatus. Tohoku J Exp Med 1997;181:411-129.
3. Kimura G, Brenner BM: A method for distinguishing salt-sensitive from non-salt-sensitive forms of human and experimental hypertension. Curr Opin Nephrol Hypertens 1993;2:341-349.
4. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
5. Imig JD, Inscho EW: Adaptations of the renal microcirculation to hypertension. Microcirculation 2002;9:315-328.
6. Imig JD: Eicosanoid regulation of the renal vasculature. Am J Physiol 2000;279:F965-F981.
7. Arendshorst WJ, Beierwaltes WH: Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol 1979;236:F246-F251.
8. Kimura G, Imanishi M, Sanai T, Kawano Y, Kojima S, Yoshida K, Abe H, Ashida T, Yoshimi H, Kawamura M, Omae T: Intrarenal hemodynamics in patients with essential hypertension. Circ Res 1991;69:421-128.
9. Bataillard A, Lo M, Sassard J: Renal circulation in genetic experimental hypertension; in Anderson WP, Evans RG, Sevenson KM (eds): Advances in Organ Biology. Stanford, JAI Press, 2000, vol 9, pp 317-329.
10. Bernard N, Sacquet J, Benzoni D, Sassard J: Cyclooxygenase 1 and 2 and thromboxane synthase in kidneys of Lyon hypertensive rats. Am J Hypertens 2000;13:404-109.
11. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N: Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 1994;24:301-308.
12. Skov K, Fenger-Gron J, Mulvany MJ: Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and an endothelin receptor antagonist on renal afferent arteriolar structure. Hypertension 1996;28:464-171.
13. Campese VM: Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994;23:531-550.
14. Kimura G, Frem GJ, Brenner BM: Renal mechanisms of salt sensitivity in hypertension. Curr Opin Nephrol Hypertens 1994;3:1-2.
15. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 1996;49:1774-1777.
16. Juncos LA, Garvin J, Carretero OA, Ito S: Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J Clin Invest 1995;95:2741-2748.
17. Ito S, Carretero OA: An in vitro approach to the study of macula densa mediated glomerular hemodynamics. Kidney Int 1990;38:1206-1210.
18. Holstein-Rathlow N, Marsh D: Oscillation of tubular pressure, flow and distal chloride concentration in rats. Am J Physiol 1989;256:F1007-F1014.
19. Ren Y, Garvin JL, Carretero OA: Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int 2001;59:222-229.
20. Ito S, Arima S, Ren Y, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates Ang II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993;91:2012-2019.
21. Ito S, Juncos LA, Carretero OA: Pressure-induced constriction of the afferent arteriole of spontaneously hypertensive rats. Hypertension 1992;19(suppl II):164-167.
22. Welch WJ, Tojo A, Wilcox CS: Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol 2000;278:F769-F776.
23. Brannstrom K, Morsing P, Arendshorst WJ: Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and ATI receptors. Am J Physiol 1996;270:F749-F755.
24. 450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. Br J Pharmacol 1999;127:1399-1405.
25. Roman RJ: P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2001;82:131-185.
26. Welch WJ, Wilcox CS: ATI receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 2001;59:1257-1263.
27. 2 contributes to the enhanced tubuloglomerular feedback activity in young SHR. Am J Physiol 1999;276:F758-F766.
28. Konieczkowski M, Dunn MJ, Stork JE, Hassid A: Glomerular synthesis of prostaglandins and thromboxane in spontaneously hypertensive rats. Hypertension 1983;5:446-152.
29. 2 biosynthesis in the kidney of spontaneously hypertensive rats during development of hypertension. Eur J Pharmacol 1981;70:247-256.
30. Mistry M, Muirhead EE, Yamaguchi Y, Nasjletti A: Renal function in rats with angiotensin II-saltinduced hypertension: Effect of thromboxane synthesis inhibition and receptor blockade. J Hypertens 1990;8:75-83.
31. Wilcox CS, Welch WJ, Snellen H: Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 1991;40:1090-1097.
32. Berecek KH, Schwertschlag U, Gross F: Alterations in renal vascular resistance and reactivity in spontaneously hypertensive rats. Am J Physiol 1980;238:H287-H293.
33. Dilley JR, Stier CT, Arendshorst WJ: Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol 1984;246:F12-F20.
34. Guidi E, Hollenberg NK: Differential pressor and renal vascular reactivity to angiotensin II in spontaneous hypertensive and Wistar-Kyoto rats. Hypertension 1987;9:591-597.
35. Beierwaltes WH, Arendshorst WJ, Klemmer PJ: Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 1982;4:908-915.
36. EndoY, Arima S,Yaoita H,Tsunoda K, Omata K, Ito S: Vasodilation mediated by angiotensin type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vase Res 1998;35:421-427.
37. Chatziantomiou C, Arendshorst WJ: Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol 1993;265:F853-F862.
38. Arendshorst WJ, Chatziantomiou C, Daniels FH: Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int 1990;38(suppl 30):92-96.
39. Chatziantomiou C, Ruan X, Arendshorst WJ: Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol 1993;265:F845-F852.
40. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997;100:2816-2823.
41. 450 metabolites in the vascular action of angiotensin II on the afferent arteriole. Hypertens Res 2001;24:551-543.
42. Arima S, Omata K, Ito S, Tsunoda K, Abe K: 20-HETE requires increased vascular tone to constrict rabbit afferent arterioles. Hypertension 1996;27:781-785.
43. Morrow JD, Harris TM, Roberts LJ: Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurements of eicosanoids. Anal Biochem 1990;184:1-10.
44. 2-isoprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol 1995;6:1300-1303.
45. 2α in the rat. J Clin Invest 1992;90:136-141.
46. Arima S, Ito S: The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy. Nephrol Dial Transplant 2003;18:1966-1969.
47. Hayashi K, Epstein M, Loutzenhiser R, Forster H: Impaired myogenic responsiveness of the rats afferent arteriole in streptozotocin-diabetic rats: Role of eicosanoid derangements. J Am Soc Nephrol 1992;2:1578-1586.
48. Hall GE, Guyton AC, Smith MJ Jr, Coleman TG: Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin. Am J Physiol 1980;239:F271-F280.
49. Abe K, Imai Y, Sato M, Haruyama T, Sato K, Hiwatari M, Kasai Y, Itoh S, Yasujima M, Seino M, Yoshinaga K: Exaggerated fractional sodium excretion in hypertension with advanced renal disease: The role of renin prostaglandin and kallikrein. Clin Sci1981;61:327S-330S.
50. Abe K, Sato M, Imai Y, Haruyama T, Sato K, Hiwatari M, Kasai Y, Yoshinaga K: Renal kallilreinkinin: Its relation to renal prostaglandins and renin-angiotensin aldosterone in man. Kidney Int 1981;19:869-880.
51. 2 receptor. Nat Med 1999;5:217-220.
52. 2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest 1995;95:2734-2740.
53. Arima S, Ren Y, Juncos LA, Carretero OA, Ito S: Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int 1994;45:650-658.
54. Nadler JL, McKay M, Campese V Vrbanac J, Horton R: Evidence that prostacyclin modulates the vascular actions of calcium in man. J Clin Invest 1986;77:1278-1284.
55. 4 on glomerular dynamics in the rat. Am J Physiol 1987;253:F239-F243.